NO175487C - Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav - Google Patents

Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav

Info

Publication number
NO175487C
NO175487C NO852776A NO852776A NO175487C NO 175487 C NO175487 C NO 175487C NO 852776 A NO852776 A NO 852776A NO 852776 A NO852776 A NO 852776A NO 175487 C NO175487 C NO 175487C
Authority
NO
Norway
Prior art keywords
preparation
derivatives
human interferon
recombinant plasmids
amino acids
Prior art date
Application number
NO852776A
Other languages
English (en)
Norwegian (no)
Other versions
NO852776L (no
NO175487B (no
Inventor
Seiga Itoh
Yasutoshi Takeichi
Moriyuki Sato
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15350817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO175487(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO852776L publication Critical patent/NO852776L/no
Publication of NO175487B publication Critical patent/NO175487B/no
Publication of NO175487C publication Critical patent/NO175487C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO852776A 1984-07-11 1985-07-10 Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav NO175487C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14395084A JPS6124599A (ja) 1984-07-11 1984-07-11 新規ヒトインタ−フエロン−ｒポリペプチド誘導体

Publications (3)

Publication Number Publication Date
NO852776L NO852776L (no) 1986-01-13
NO175487B NO175487B (no) 1994-07-11
NO175487C true NO175487C (no) 1994-10-19

Family

ID=15350817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852776A NO175487C (no) 1984-07-11 1985-07-10 Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav

Country Status (11)

Country Link
US (1) US4898931A (de)
EP (1) EP0170917B1 (de)
JP (1) JPS6124599A (de)
AT (1) ATE63923T1 (de)
AU (1) AU586822B2 (de)
CA (1) CA1303529C (de)
DE (2) DE3582973D1 (de)
DK (1) DK164108C (de)
ES (1) ES8609484A1 (de)
IL (1) IL75738A (de)
NO (1) NO175487C (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334102D0 (en) * 1983-12-21 1984-02-01 Searle & Co Interferons with cysteine pattern
CA1340265C (en) * 1985-01-18 1998-12-15 Kirston E. Koths Oxidation resistant muteins
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
AT393690B (de) * 1987-10-08 1991-11-25 Hoffmann La Roche Homogene, rekombinante immun-interferonfragmente
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
DE4036856C1 (de) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
CN1900116A (zh) * 1995-01-26 2007-01-24 拜奥根Idec马萨诸塞公司 抗－LT－β－R抗体、含有该抗体的药用组合物及其制药应用
DE19535853C2 (de) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2003513681A (ja) * 1999-11-12 2003-04-15 マキシゲン・ホールディングス・リミテッド インターフェロンガンマ・コンジュゲート
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
AU782635B2 (en) * 1999-11-12 2005-08-18 Maxygen Holdings Ltd. Interferon gamma conjugates
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US7524931B2 (en) 2002-07-03 2009-04-28 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
JP4896745B2 (ja) 2004-02-02 2012-03-14 アンブレツクス・インコーポレイテツド 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用
CA2609205A1 (en) * 2005-06-03 2006-12-14 Ambrx, Inc. Improved human interferon molecules and their uses
EP1991679A2 (de) * 2006-03-08 2008-11-19 Biomethodes Varianten des humanen interferon-gamma (ifngamma)
FR2898359B1 (fr) * 2006-03-08 2011-07-15 Biomethodes Variants ameliores de l'interferon-gamma humain (ifn gamma)
CA2712606A1 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
MX2021001165A (es) * 2018-07-30 2021-07-15 Univ Leland Stanford Junior Agonistas sesgados de interferon-gamma.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
IL69851A0 (en) * 1982-09-30 1983-12-30 Japan Found Cancer Novel dna and recombinant plasmid containing the same
US4758656A (en) * 1983-12-26 1988-07-19 Kyowa Hakko Kogyo Co., Ltd. Novel human interferon-gamma polypeptide derivative
AU582574B2 (en) * 1984-04-19 1989-04-06 Hoechst Aktiengesellschaft The preparation of polypeptides having human gamma interferon activity
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof

Also Published As

Publication number Publication date
ATE63923T1 (de) 1991-06-15
EP0170917A1 (de) 1986-02-12
ES545052A0 (es) 1986-09-01
EP0170917B1 (de) 1991-05-29
DK314485D0 (da) 1985-07-10
DE3582973D1 (de) 1991-07-04
CA1303529C (en) 1992-06-16
NO852776L (no) 1986-01-13
DK164108B (da) 1992-05-11
NO175487B (no) 1994-07-11
AU4474985A (en) 1986-01-16
DK164108C (da) 1992-10-12
ES8609484A1 (es) 1986-09-01
IL75738A0 (en) 1985-11-29
AU586822B2 (en) 1989-07-27
JPS6124599A (ja) 1986-02-03
IL75738A (en) 1995-06-29
DE170917T1 (de) 1986-09-04
DK314485A (da) 1986-01-12
US4898931A (en) 1990-02-06

Similar Documents

Publication Publication Date Title
NO175487C (no) Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav
NO164177C (no) Rekombinant dna-fremgangsmaate for fremstilling av et polypeptid med funksjon av human immun (gamma)-interferon.
EP0201743A3 (en) Dipeptide derivatives of fatty acids, process for preparing them, pharmaceutical composition and use
EP0243929A3 (en) Polypeptide and protein derivatives and process for their preparation
GB2037296B (en) Purified proteins expecially interferon and process therefor
GB8812993D0 (en) Improvements in/relating to production of protein products
AU2535188A (en) Pharmaceutical compositions of recombinant beta-interferon and formulation processes
JPS539762A (en) Hydoxyysuccinimideeester derivative* its preparation and method of bonding biologically active proteins
IL61058A0 (en) Derivatives of amino acids and process for their preparation
DE3873397D1 (de) Bifunktionelle proteine.
NZ209590A (en) Gamma interferon analogue, preparation and pharmaceutical composition
AU2421588A (en) Procaryotic xylose isomerase muteins and method to increase protein stability
PT83952A (en) Process for the preparation of new oxygenated-alkyl derivatives of glutamic and aspartic acids with antagonistic activity to bio-active polypeptides
PL261087A1 (en) Method of obtaining novel derivatives of amino acids
FI875319A0 (fi) Bisyklisten aminokarboksyylihappojen johdannaiset, menetelmä niiden valmistamiseksi ja niiden valmistuksessa käytettävät välituotteet, sekä niiden käyttö
FI102282B1 (fi) Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi
EP0448605A4 (en) Use of basic amino acids to solubilize immunoglobulins
ZA891534B (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
IT8268431A0 (it) Plicazione terapeutica n vinblastin 23 il derivati di amminoacidi loro preparazione ed ap
AU585524B2 (en) Process for preparing milk protein resistant to acids and bases
NZ235774A (en) Peptide with amino acid sequence homologous to portion of porcine somatotropin; antibodies and their use in potentiating the activity of pst
IL78865A (en) Derivatives of bicyclic amino acids,process for their preparation and pharmaceutical compositions containing them
EP0219839A3 (de) Derivat des Interleukin-2, seine Herstellung und Verwendung
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus